Zarranz-Ventura J - Search Results

1

Safety of 6000 intravitreal dexamethasone implants.

Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group. Rajesh B, et al. Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30. Br J Ophthalmol. 2020. PMID: 31040132

2

Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries.

Loewenstein A, Berger A, Daly A, Creuzot-Garcher C, Gale R, Ricci F, Zarranz-Ventura J, Guymer R. Loewenstein A, et al. Eye (Lond). 2023 Nov;37(16):3351-3359. doi: 10.1038/s41433-023-02540-w. Epub 2023 Jun 6. Eye (Lond). 2023. PMID: 37280350 Free PMC article. Review.

3

Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries.

Loewenstein A, Berger A, Daly A, Creuzot-Garcher C, Gale R, Ricci F, Zarranz-Ventura J, Guymer R. Loewenstein A, et al. Eye (Lond). 2024 Feb;38(2):408. doi: 10.1038/s41433-023-02662-1. Eye (Lond). 2024. PMID: 37528179 Free PMC article. No abstract available.

4

Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.

Salinas-Alamán A, Zarranz-Ventura J, Caire González-Jauregui JM, Sádaba-Echarri LM, Barrio-Barrio J, García-Layana A. Salinas-Alamán A, et al. Eur J Ophthalmol. 2011 Jul-Aug;21(4):434-9. doi: 10.5301/EJO.2010.6101. Eur J Ophthalmol. 2011. PMID: 21140369

5

Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency.

Zarranz-Ventura J, Carreño E, Johnston RL, Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A. Zarranz-Ventura J, et al. Am J Ophthalmol. 2014 Dec;158(6):1136-1145.e5. doi: 10.1016/j.ajo.2014.09.003. Epub 2014 Sep 8. Am J Ophthalmol. 2014. PMID: 25217856

6

UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections.

Madhusudhana KC, Lee AY, Keane PA, Chakravarthy U, Johnston RL, Egan CA, Sim D, Zarranz-Ventura J, Tufail A, McKibbin M; UK AMD EMR Study Group. Madhusudhana KC, et al. Br J Ophthalmol. 2016 Dec;100(12):1617-1622. doi: 10.1136/bjophthalmol-2015-308077. Epub 2016 Mar 30. Br J Ophthalmol. 2016. PMID: 27030276

7

Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world.

Zarranz-Ventura J, Sala-Puigdollers A, Velazquez-Villoria D, Figueras-Roca M, Copete S, Distefano L, Boixadera A, García-Arumi J, Adan A; Hospital Clínic—Hospital Vall de Hebron Intravitreal Dexamethasone Implant study group. Zarranz-Ventura J, et al. PLoS One. 2019 Jan 4;14(1):e0209997. doi: 10.1371/journal.pone.0209997. eCollection 2019. PLoS One. 2019. PMID: 30608950 Free PMC article.

8

Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema.

Figueras-Roca M, Sala-Puigdollers A, Zarranz-Ventura J, Alba-Linero C, Alforja S, Esquinas C, Molins B, Adán A. Figueras-Roca M, et al. Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1336-1343. doi: 10.1167/iovs.18-26215. Invest Ophthalmol Vis Sci. 2019. PMID: 30933261

9

Long-Term Intravitreal Dexamethasone Implant Outcomes in Uveitis.

Alba-Linero C, Sala-Puigdollers A, Romero B, Llorenç V, Adan A, Zarranz-Ventura J. Alba-Linero C, et al. Ocul Immunol Inflamm. 2020;28(2):228-237. doi: 10.1080/09273948.2019.1578380. Epub 2019 Apr 17. Ocul Immunol Inflamm. 2020. PMID: 30994370

10

Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.

Figueras-Roca M, Sala-Puigdollers A, Alforja S, Torras J, Peraza-Nieves J, Zarranz-Ventura J, Adan Civera A, Molins B. Figueras-Roca M, et al. Ocul Immunol Inflamm. 2019;27(8):1203-1210. doi: 10.1080/09273948.2019.1636095. Epub 2019 Aug 16. Ocul Immunol Inflamm. 2019. PMID: 31418610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page